The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with

E Prat1, P Baron, L Meda

  • 1Institute of Neurology, Dino Ferrari Center, University of Milan, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122, Milan, Italy.

Neuroscience Letters
|April 8, 2000
PubMed

Insights

Beta-amyloid (Abeta) peptides stimulate astrocytes to produce monocyte chemotactic protein-1 (MCP-1). This finding helps explain how Abeta contributes to damage in Alzheimer's disease senile plaques.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Astrocytes, a type of glial cell, are found near beta-amyloid (Abeta) deposits in Alzheimer's disease (AD) senile plaques.
  • The interaction between Abeta and astrocytes is crucial for understanding AD pathogenesis.

Purpose of the Study:

  • To investigate the biological effects of Abeta/astrocyte interactions.
  • To examine chemokine production by human astrocytoma cells stimulated with Abeta peptides.

Main Methods:

  • Utilized the human astrocytoma cell line U373MG.
  • Stimulated cells with Abeta [1-42] and Abeta [25-35] peptides.
  • Employed Northern blot analysis and specific immunoassays to detect gene expression and protein release.

Main Results:

  • Abeta [1-42] and Abeta [25-35] significantly induced mRNA expression and release of monocyte chemotactic protein-1 (MCP-1) in U373MG cells.
  • The study found no induction of gamma-interferon inducible protein (IP)-10 by Abeta peptides in these cells.
  • Abeta peptides trigger astrocytes to produce MCP-1, a chemoattractant for microglia.

Conclusions:

  • Abeta peptides stimulate astrocytes to produce MCP-1.
  • This astrocyte-derived MCP-1 may contribute to the recruitment of microglia and subsequent damage in Alzheimer's disease senile plaques.
  • Understanding this mechanism provides insight into Abeta-mediated neuroinflammation in AD.

Related Concept Videos